A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 16, Issue 5-6, 2015, Pages 331-337

  Franchignoni, Franco ^a   Mandrioli, Jessica ^b,d   Giordano, Andrea ^a   Ferro, Salvatore ^c   Fini, N ^d   Georgoulopoulou, E ^d   Nichelli, P ^d   Biguzzi, S ^e   Venturini, E ^e   Passarin, M G ^e   Guidi, C ^f   Neri, W ^f   Sette, E ^g   Tugnoli, V ^g   Tola, M R ^g   Terlizzi, E ^h   Guidetti, D ^h   Curro Dossi, M ⁱ   Pasquinelli, M ⁱ   Andruccioli, J ⁱ   Ravasio, A ⁱ   Casmiro, M ^j   Rasi, F ^j   Salvi, F ^k   Bartolomei, I ^k   Michelucci, R ^k   Avoni, P ^l   De Pasqua, S ^l   Liguori, R ^l   Rizzi, R ^m   Canali, E ^m   Marcello, N ^m   Grassi, A ⁿ   Delay, L ⁿ   Pietrini, V ⁿ   Aiello, M ⁿ   Chierici, E ^o   Montanari, E ^o   Santangelo, M ^p   Amidei, S ^p   Greco, G ^p   Casetta, I ^q   Groppo, E ^q   Granieri, E ^q   De Massis, P ^r   Mussuto, V ^r   Borghi, A ^s   Gabellini, A ^s   Sacquegna, T ^s   Rinaldi, R ^t   Cirignotta, F ^t   D'Alessandro, R ^u   Ferro, S ^c   more..

^a IRCCS   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c Drug Policy Service   (Italy)

^d S Agostino Estense Hospital   (Italy)

^e BUFALINI HOSPITAL   (Italy)

^f Forli Hospital   (Italy)

^g S ANNA HOSPITAL   (Italy)

^h GUGLIELMO DA SALICETO HOSPITAL   (Italy)

ⁱ INFERMI HOSPITAL   (Italy)

^j Faenza and Ravenna Hospital ^*  (Italy)

^k BELLARIA HOSPITAL   (Italy)

^l UNIVERSITY OF BOLOGNA   (Italy)

^m S MARIA NUOVA HOSPITAL   (Italy)

ⁿ UNIVERSITY OF PARMA   (Italy)

^o Fidenza Hospital   (Italy)

^p Carpi Hospital   (Italy)

^q UNIVERSITY OF FERRARA   (Italy)

^r Hospital of Imola   (Italy)

^s MAGGIORE HOSPITAL   (Italy)

^t UNIVERSITY OF BOLOGNA   (Italy)

^u UOC di Neuropsichiatria Dell'età Pediatrica   (Italy)

more..

Author keywords

ALSFRS R; Amyotrophic lateral sclerosis; population based study; Rasch analysis

Indexed keywords

AGED; AMBIGUITY; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE REVISED; ARTICLE; CLIMBING; CLINICAL ASSESSMENT TOOL; DYSPNEA; FACTORIAL ANALYSIS; FEMALE; HANDWRITING; HUMAN; HYGIENE; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOMETRY; RASCH ANALYSIS; REGISTER; RESPIRATORY FAILURE; SALIVATION; SPEECH; SWALLOWING; WALKING; ADULT; HEALTH CARE PLANNING; MIDDLE AGED; PSYCHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; COMMUNITY HEALTH PLANNING; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; RETROSPECTIVE STUDIES;

EID: 84945123953     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2015.1026829     Document Type: Article

References (25)

1. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169: 13-21.
2. Kaufmann P, Levy G, Montes J, Buchsbaum R, Barsdorf AI, Battista V, et al. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial. Amyotroph Lateral Scler. 2007; 8: 42-6.
3. Kasarskis EJ, Dempsey-Hall L, Thompson MM, Luu LC, Mendiondo M, Kryscio R. Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6: 50-4.
4. Miano B, Stoddard GJ, Davis S, Bromberg MB. Inter-evaluator reliability of the ALS functional rating scale. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 235-9.
5. Mannino M, Cellura E, Grimaldi G, Volanti P, Piccoli F, La Bella V. Telephone follow-up for patients with amyotrophic lateral sclerosis. Eur J Neurol. 2007; 14: 79-84.
6. Maier A, Holm T, Wicks P, Steinfurth L, Linke P, Münch C, et al. Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial. Amyotroph Lateral Scler. 2012; 13: 210-6.
7. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol. 1996; 53: 141-7.
8. Kaufmann P, Levy G, Thompson JL, Delbene ML, Battista V, Gordon PH, et al. The ALSFRS-R predicts survival time in an ALS clinic population. Neurology. 2005; 64: 38-43.
9. A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology. 1999; 52: 1427-33.
10. Groeneveld GJ, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, et al. A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Ann Neurol. 2003; 53: 437-45.
11. Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr, Johnson H, Qureshi M, et al. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology. 2003; 61: 456-64.
12. Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, et al. Clinical trial of creatine in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003; 4 (Suppl):28, C31.
13. Chiò A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, et al. ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology. 2011; 77: 1432-7.
14. Wicks P, Massagli MP, Wolf C, Heywood J. Measuring function in advanced ALS: validation of ALSFRS-EX extension items. Eur J Neurol. 2009; 16: 353-9.
15. Gordon PH, Cheng B, Salachas F, Pradat PF, Bruneteau G, Corcia P, et al. Progression in ALS is not linear but is curvilinear. J Neurol. 2010; 257: 1713-7.
16. Franchignoni F, Mora G, Giordano A, Volanti P, Chiò A. Evidence of multidimensionality in the ALSFRS-R scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry. 2013; 84: 1340-5.
17. Mandrioli J, Biguzzi S, Guidi C, Venturini E, Sette E, Terlizzi E, et al. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15: 262-8.
18. Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS progression. J Neurol Sci. 2008; 275: 69-73.
19. Hu L, Bentler PM. Cut-off criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equat Model. 1999; 6: 1-55.
20. Linacre JM. Optimizing rating scale category effectiveness. J Appl Meas. 2002; 3: 85-106.
21. Wolfe EW, Smith EV Jr. Instrument development tools and activities for measure validation using Rasch models: part II-validation activities. J Appl Meas. 2007; 8: 204-23.
22. Bond TG, Fox CM. Applying the Rasch model: fundamental measurement in the human sciences, 2nd edn. Mahwah, NJ: Lawrence Erlbaum Associates; 2007. pp 219-33.
23. Stout W. A non-parametric approach for assessing latent trait unidimensionality. Psychometrika. 1987; 52: 589-617.
24. Pinto S, de Carvalho M. The R of ALSFRS-R: does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep 10: 1-4. [Epub ahead of print].
25. Linacre JM. A user's guide to WINSTEPS-MINISTEP: Rasch-model computer programs. Program manual 3.75.0 [Internet] 2012 [cited 12/15/2014]; page 523. Available with full text from: http://www.winsteps.com/a/winsteps.pdf